Evidence for the lack of involvement of sphingomyelin hydrolysis in the tumor necrosis factor-induced secretion of nerve growth factor in primary astrocyte cultures

Journal of Neurochemistry

Volumn 71, Issue 2, 1998, Pages 498-505

  Galve Roperh, Ismael ^a   Sánchez, Cristina ^a   Ségui, Bruno ^c   Haro, Amador ^a   Díaz Laviada, Ines ^b   Levade, Thierry ^c  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c INSERM   (France)

Author keywords

Astrocytes; Ceramide; Nerve growth factor; NF B; Sphingomyelin; Tumor necrosis factor

Indexed keywords

ARSENOSOBENZENE; CERAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE INHIBITOR; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; IMMUNOMODULATION; IMMUNOSTIMULATION; NERVE GROWTH; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0031755353     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71020498.x     Document Type: Article

References (47)

1. Ahmad F. and Goldstein B. J. (1997) Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases. J. Cell. Biochem. 64, 117-127.
2. Alessi D. R., Cuenda A., Cohen P., Dudley D. T., and Saltiel A. R. (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494.
3. Ames B. N. (1966) Assay of inorganic phosphate, total phosphate and phosphatases. Methods Enzymol. 8, 115-118.
4. Andrieu N., Salvayre R., and Levade T. (1994) Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts. Biochem. J. 303, 341-345.
5. Andrieu N., Salvayre R., Jaffrézou J. P., and Levade T. (1995) Low temperatures and hypertonicity do not block cytokine-induced stimulation of the sphingomyelin pathway but inhibit nuclear factor-κB activation. J. Biol. Chem. 270, 24518-24524.
6. Andrieu N., Salvayre R., and Levade T. (1996) Comparative study of the metabolic pools of sphingomyelin and phosphatidylcholine sensitive to tumor necrosis factor. Eur. J. Biochem. 236, 738-745.
7. Betts J. C., Agranoff A. B., Nabel G. J., and Shayman J. A. (1994) Dissociation of endogenous cellular ceramide from NF-κB activation. J. Biol. Chem. 269, 8455-8458.
8. Bielawska A., Greenberg M. S., Perry D., Jayadev S., Shayman J. A., McKay C., and Hannun Y. (1996) (1S,2R)-D-erythro-(N-Myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase. J. Biol. Chem. 271, 12646-12654.
9. Bose R., Verheij M., Haimovitz-Friedman A., Scotto K., Fuks Z., and Kolesnick R. (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82, 405-414.
10. Dopp J. M., Mackenzie-Graham A., Otero G. C., and Merrill J. E. (1997) Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J. Neuroimmunol. 75, 104-112.
11. Friedman W. J., Thakur S., Seidman L., and Rabson A. B. (1996) Regulation of nerve growth factor mRNA by interleukin-1 in rat hippocampal astrocytes is mediated by NFκB. J. Biol. Chem. 271, 31115-31120.
12. Galve-Roperh I., Haro A., and Diaz-Laviada I. (1997a) Induction of nerve growth factor synthesis by sphingomyelinase and ceramide in primary astrocyte cultures. Mol. Brain Res. 52, 90-97.
13. Galve-Roperh I., Malpartida J. M., Haro A., Brachet P., and Diaz-Laviada I. (1997b) Regulation of nerve growth factor secretion and mRNA expression by bacterial lipopolysaccharide in primary cultures of rat astrocytes. J. Neurosci. Res. 49, 569-575.
14. Galve-Roperh I., Haro A., and Diaz-Laviada I. (1997c) Ceramide induced translocation of protein kinase C ζ in primary cultures of astrocytes. FEBS Lett. 415, 271-274.
15. Gamard C. J., Dbaibo G. S., Liu B., Obeid L. M., and Hannun Y. (1997) Selective involvement of ceramide in cytokine-induced apoptosis. Ceramide inhibits phorbol ester activation of nuclear factor kappa B. J. Biol. Chem. 272, 16474-16481.
16. Hannun Y. A. (1996) Functions of ceramide in coordinating cellular responses to stress. Science 274, 1855-1859.
17. Hattori A., Tanaka E., Murase K., Ishida N., Chatani Y., Tsujimoto M., Hayashi K., and Kohno M. (1993) Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non-neural cells. J. Biol. Chem. 268, 2577-2582.
18. Hattori A., Hayashi K., and Kohno M, (1996) Tumor necrosis factor (TNF) stimulates the production of nerve growth factor in fibroblasts via the 55-kDa type 1 TNF receptor. FEBS Lett. 379, 157-160.
19. Huwiler A., Brunner J., Hummel R., Vervoordeldonk M., Stabel S., Van der Bosh H., and Pfeilschifter J. (1996) Ceramide-binding and activation define protein kinase c-raf as a ceramide-activated protein kinase. Proc. Natl. Acad. Sci. USA 93, 6959-6963.
20. Jayadev S., Linardic C. M., and Hannun Y. A. (1994) Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor α. J. Biol. Chem. 269, 5757-5763.
21. Jehan F., Neveu I., Naveilhan P., Brachet P., and Wion D. (1993) Complex interactions among second messenger pathways, steroid hormones, and protooncogenes of the Fos and Jun families converge in the regulation of the nerve growth factor gene. J. Neurochem. 60, 1843-1853.
22. Krejsa C. M., Nadler S. G., Esselstyn J. M., Kavanagh T. J., Ledbetter J. A., and Schieven G. L. (1997) Role of oxidative stress in the action of vanadium phosphotyrosine phosphatase inhibitors. J. Biol. Chem. 272, 11541-11549.
23. Kuno K., Sukegawa K., Ishikawa Y., Orii T., and Matsushima K. (1994) Acid sphingomyelinase is not essential for the IL-1 and tumor necrosis factor receptor signaling pathway leading to NF-κB activation. Int. Immunol. 6, 1269-1272.
24. Kurino M., Fukunaga K., Ushio Y., and Miyamoto E. (1996) Cyclic AMP inhibits activation of mitogen-activated protein kinase and cell proliferation in response to growth factors in cultured rat cortical astrocytes. J. Neurochem. 67, 2246-2255.
25. Laviada I. D., Baudet C., Galve-Roperh I., Naveilhan P., and Brachet P. (1995) Phosphatidylcholine-phospholipase C mediates the induction of nerve growth factor in cultured glial cells. FEBS Lett. 364, 301-304.
26. Lozano J., Berra E., Municio M. M., Diaz-Meco M. T., Dominguez I., Sanz L., and Moscat J. (1994) Protein kinase C ζ isoform is critical for κB-dependent promoter activation by sphingomyelinase. J. Biol. Chem. 269, 19200-19202.
27. Machleidt T., Wiegmann K., Henkel T., Schutze S., Bauerle P., and Kränke M. (1994) Sphingomyelinase activates proteolytic IκB-degradation in a cell-free system. J. Biol. Chem. 269, 13760-13765.
28. Merrill J. E. and Benveniste E. N. (1996) Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19, 331-338.
29. Modur V., Zimmerman G. A., Prescott S. M., and McIntyre T. M. (1996) Endothelial cell inflammatory responses to tumor necrosis factor α. J. Biol. Chem. 271, 13094-13102.
30. Neveu I., Naveilhan P., Jehan F., Baudet C., Wion D., De Luca H. F., and Brachet P. (1994) 1,25-Dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Mol. Brain Res. 24, 70-76.
31. O'Neill L. and Kaltschmidt C. (1997) NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20, 252-258.
32. Pahan K., Namboodiri A. M. S., Sheikh F. G., Smith B. T., and Singh I. (1997) Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes. J. Biol. Chem. 272, 7786-7791.
33. Pahan K., Sheikh F. G., Khan M., Namboodiri A. M. S., and Singh I. (1998) Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. J. Biol. Chem. 273, 2591-2600.
34. Paumen M. B., Ishida Y., Muramatsu M., Yamamoto M., and Honjo T. (1997) Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. J. Biol. Chem. 272, 3324-3329.
35. Pshenichkin S. P., Szckely A. M., and Wise B. C. (1994) Transcriptional and posttranscriptional mechanisms involved in the interleukin-1, steroid, and protein kinase C regulation of nerve growth factor in cortical astrocytes. J. Neurochem. 63, 419-428.
36. Richard A., Robichaud G., Lapointe R., Bourgoin S., Darveau A., and Poulin L. (1996) Interference of HIV-1 nef in the sphingomyelin transduction pathway activated by tumor necrosis factor-α in human glial cells. AIDS 11, F1-F7.
37. Sawai H., Okazaki T., Yamamoto H., Okano H., Takeda Y., Tashima M., Sawada H., Okuma M., Ishikura H., Umehara H., and Domae N. (1995) Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J. Biol. Chem. 270, 27326-27331.
38. Schütze S., Potthoff K., Machleidt T., Berkovic D., Wiegmann K., and Kronke M. (1992) TNF activates NF-κB by phosphatidylcholine-speciric phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71, 765-776.
39. Singh S. and Aggarwal B. B. (1995) Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-κB. J. Biol. Chem. 270, 10631-10639.
40. Spiegel S., Foster D., and Kolesnick R. (1996) Signal transduction through lipid second messengers. Curr. Opin. Cell Biol. 8, 159-167.
41. Van Dijk M. C. M., Hilkman H., and Van Blitterswijk W. J. (1997) Platelet-derived growth factor activation of mitogen-activated protein kinase depends on the sequential activation of phosphatidylcholine-specific phospholipase C, protein kinase C-ζ and Raf-1. Biochem. J. 325, 303-307.
42. Van Veldhoven P. P., Mathews J. J., Bolognesi D. P., and Bell R. M. (1992) Changes in bioactive lipids, alkylacylglycerol and ceramide, occur in HIV-infected cells. Biochem. Biophys. Res. Commun. 187, 209-216.
43. Wiegmann K., Schütze S., Machleidt T., Witte D., and Krönke M. (1994) Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78, 1005-1015.
44. Willis S. A. and Nisen P. D. (1996) Differential induction of the mitogen activated protein kinase pathway by bacterial lipopolysaccharide in cultured monocytes and astrocytes. Biochem. J. 313, 519-524.
45. Yu J., Wiley R. G., and Perez-Polo R. J. (1996) Altered NGF protein levels in different brain areas after immunolesion. J. Neurosci. Res. 43, 213-223.
46. Zhang P., Miller B. S., Rosenzweig S. A., and Bhat N. R. (1996) Activation of the c-Jun N-terminal kinase/stress-activated protein kinase in primary glial cultures. J. Neurosci. Res. 46, 114-121.
47. Zumbansen M. and Stoffel W. (1997) Tumor necrosis factor α activates NF-κB in acid sphingomyelinase-deficient mouse embryonic fibroblasts. J. Biol. Chem. 272, 10904-10909.